2bPrecise is developing the needed ontology for its platform to enable clinicians to combine genomic and clinical data in their interactions with pediatric patients.
The company plans to use Thermo Fisher Scientific's newly launched PharmacoScan array-based platform for its testing.
The researchers said that the goal was to design a model that other health care institutions could integrate in order to standardize PGx testing.
Researchers were able to predict the expression of certain genes in 44 different tissues to predict other conditions that might later arise in patients as well as identify potential therapeutic approaches.
Two research teams found potentially useful PGx variants in more than 1,000 participants in the NIH Undiagnosed Diseases Program, as well as in a handful of ClinSeq participants.
Researchers identified Neanderthal alleles associated with human conditions using genotypic and phenotypic information in health records for more than 28,000 individuals.
The company received the funding from the Spanish Ministry of Economy and Competitiveness' Centre for the Development of Industrial Technology.
The companies are combining their respective software platforms to provide an end-to-end genomic testing solution for hospital labs.
The companies will create a cloud-based platform combining Guardant Health's liquid biopsy testing results with patient clinical data.
The program comprises several centers aimed at genetic and pharmacogenomic testing in order to tailor the diagnosis and treatment of patients.
A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.
A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.
Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.
In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.